Related Experiment Video
Updated: Jun 16, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemia
Hendrik J M de Jonge1, Carolien M Woolthuis, Eveline S J M de Bont
1Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract:
Aging is generally considered to be the consequence of stem cell attrition caused by the activity of tumor suppressor pathways that censor potentially malignant clones by eliciting apoptosis or senescence. An important effector of aging is the cyclindependent kinase inhibitor p16(INK4a), which is also a known suppressor of cancer. The expression of p16(INK4a) is very low or absent in young organisms but increases with advancing age. We recently showed that, unlike healthy cells, acute myeloid leukemia (AML) derived blasts show a down-regulation of p16(INK4a) mRNA with increasing age. Based on this observation we hypothesize that suppression of defense mechanisms which protect older cells against cellular and DNA damage might facilitate oncogenesis in older individuals.
Insights
Aging results from stem cell loss, partly due to tumor suppressor pathways. We found that decreased p16(INK4a) in older acute myeloid leukemia cells may promote cancer development in aging individuals.
Area of Science:
- Oncology
- Aging Research
- Cellular Biology
Background:
- Aging is linked to stem cell attrition and the activation of tumor suppressor pathways like p16(INK4a).
- p16(INK4a) expression increases with age and acts as a cancer suppressor.
- Acute myeloid leukemia (AML) blasts exhibit distinct age-related expression patterns of p16(INK4a) compared to healthy cells.
Purpose of the Study:
- To investigate the role of p16(INK4a) in age-related oncogenesis.
- To test the hypothesis that suppressed cellular defense mechanisms in older individuals facilitate cancer development.
Main Methods:
- Analysis of p16(INK4a) mRNA expression in AML blasts across different age groups.
- Comparison of p16(INK4a) expression in AML cells versus healthy cells.
Main Results:
- AML-derived blasts show down-regulation of p16(INK4a) mRNA with increasing age.
- This contrasts with the typical age-related increase in p16(INK4a) observed in healthy cells.
Conclusions:
- Suppression of age-related defense mechanisms, such as p16(INK4a) expression, may contribute to oncogenesis in older individuals.
- This finding suggests a potential mechanism linking aging, immune suppression, and cancer risk.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Inhibition of Cdk Activity

